Skip to content

Qualico Pharma

Active Private limited companyfounded 2024active for 2 yearsRue Général-Piron, Nov. 1, 5380 FernelmontKBO/BCE: BE 1015.581.981

Lifetime

2 annual accounts with figures on one time axis
peak of €83,528 in 2025
€83,528▲ 382%
peak of €65,048 in 2025
€65,048▲ 428%
peak of €78,691 in 2025
€78,691▲ 444%
€42,878▲ 480%
Board1 name since 2024
1 director
Documentsfilings and deeds
22-07-20269 days before the deadline
2025micro format
Gross margin from €17,318 to €83,528Result from €12,310 to €65,048Dividend €833Equity from €14,477 to €78,691Debts from €7,398 to €42,878Cash from €195 to €85,356

Key points

from the 2025 annual accounts

Equity

€78,691 ▲ 444%
14,4772024+65,048Profit-833Dividend78,6912025

Qualico Pharma paid out €833 in dividends. That is 1% of the 2025 profit.

Result

€65,048 ▲ 428%
€12,3002024€65,0002025

The result rose in 2025 from €12,310 to €65,048.

Turnover

≈ €250,000 estimated

The micro format states no turnover.

Investments

€2,900 5.8 times depreciation

Green is investment, beige is depreciation.

Position in the sector

€65,048

Higher net result than 89% of companies in other professional activities. The sector median is €9,115, over 4,571 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Qualico Pharma has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Qualico Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-10-2024
  • 100 sharesdeed of 29-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1015581981
Incorporation Founding capital of €3,000, 100 shares · Founded by · appointed as director · published on 29-10-2024 · Gazette deed
First establishment Rue Général-Piron, Nov. 1, Fernelmont
All 5 events

Comparable companies

same main activity, similar in size and age
Company
Qualico Pharma Fernelmont €121,569 €83,528 64.7% -
BRB Electromation Brecht €129,891 €89,166 46.5% -
HiTec Brecht €125,072 €86,322 52.0% -
BieJoli Kapellen €128,990 €92,531 76.8% -
LMD CONSULTING Antwerp €119,264 €96,622 49.3% -
ARCENI Binche €104,721 €89,514 64.5% -
GICC Clavier €132,048 €101,156 44.1% -

These companies have the same main activity as Qualico Pharma: other professional, scientific and technical activities (NACE 74999). They are comparable in size and age: total assets between €105,000 and €132,000, founded in 2024.

Official details

Source: KBO
Status
Active since 25-10-2024Normal situation
Activity
Other professional, scientific and technical activitiesNACE 74999and 2 others
Establishment unit
2.366.133.8665380 Fernelmont, since 25-10-2024
Financial year end
31 December
Peppol
Reachable since 09-12-2025
Company details

Annual accounts 2025

€121,569▲ 456%
Filing
Filed on 22-07-2026, 9 days before the end of the filing period
Financials

Insights on Qualico Pharma

Qualico Pharma has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €78,691 and a net result of €65,048.

Its solvency ranks better than 65% of 4,577 sector peers (NACE 74) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Qualico Pharma

What is the company number of Qualico Pharma?
The company number of Qualico Pharma is 1015.581.981. The VAT number is the same number with BE in front: BE 1015.581.981.
Where is Qualico Pharma based?
The registered office is at Rue Général-Piron, Nov. 1, 5380 Fernelmont.Company details
What does Qualico Pharma do?
According to the KBO register, the main activity is other professional, scientific and technical activities (NACE 74999).
What is the legal form of Qualico Pharma?
Qualico Pharma is a private limited company (BV).
When was Qualico Pharma founded?
Qualico Pharma was founded on 25-10-2024.
Is Qualico Pharma still active?
Yes, Qualico Pharma is an active enterprise in the KBO register.
What is the turnover of Qualico Pharma?
The turnover in financial year 2025 is about €250,000. This figure is estimated from the gross margin of €83,528 and 2,981 comparable companies of the same size. It probably lies between €160,000 and €430,000. It is a rough estimate.Financials
Is Qualico Pharma profitable?
In financial year 2025, Qualico Pharma made a profit of €65,048.
Where can I find the annual accounts of Qualico Pharma?
Qualico Pharma filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Qualico Pharma due?
Qualico Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.